Page last updated: 2024-09-03

icrf 193 and Breast Cancer

icrf 193 has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, L; Deng, CX; Tominaga, Y; Wang, A; Wang, RH; Wang, X	1

Other Studies

1 other study(ies) available for icrf 193 and Breast Cancer

Article	Year
Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe. Cell death and differentiation, 2007, Volume: 14, Issue:3 Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Breast Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Chromosome Aberrations; Diketopiperazines; DNA Damage; Gene Expression Regulation, Neoplastic; Genistein; Mice; Mitosis; Mutation; Piperazines; Polyploidy; Topoisomerase II Inhibitors	2007

Article

Year

Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe.

Cell death and differentiation, 2007, Volume: 14, Issue:3

Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Breast Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Chromosome Aberrations; Diketopiperazines; DNA Damage; Gene Expression Regulation, Neoplastic; Genistein; Mice; Mitosis; Mutation; Piperazines; Polyploidy; Topoisomerase II Inhibitors

2007